We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
DigitalOcean
DOCN
$9.24B
| $427K | 0.01% |
2,717
-17,502
| -87% | -$2.37M |
2026 Q1
1 quarter
|
|
327
Fortive
FTV
$20B
| $422K | 0.01% |
+6,916
| New | +$415K |
2026 Q2
0 quarters
|
|
328
Avalyn Pharma
AVLN
$1.31B
| $412K | 0.01% |
+12,500
| New | +$361K |
2026 Q2
0 quarters
|
|
329
Unity
U
$22.8B
| $379K | 0.01% |
+13,265
| New | +$353K |
2026 Q2
0 quarters
|
|
330
Stem
STEM
$26.6M
| $376K | 0.01% |
+48,186
| New | +$447K |
2026 Q2
0 quarters
|
|
331
Royal Caribbean
RCL
$90.1B
| $320K | 0.01% |
+1,009
| New | +$282K |
2026 Q2
0 quarters
|
|
332
Walmart Inc
WMT
$997B
| $302K | 0.01% |
2,667
-37,333
| -93% | -$4.63M |
2026 Q1
1 quarter
|
|
333
SOPHiA GENETICS
SOPH
$642M
| $288K | 0.01% |
+50,000
| New | +$254K |
2026 Q2
0 quarters
|
|
334
Builders FirstSource
BLDR
$7.1B
| $218K | ﹤0.01% |
+2,440
| New | +$195K |
2026 Q2
0 quarters
|
|
335
Applovin
APP
$136B
| $216K | ﹤0.01% |
+419
| New | +$202K |
2026 Q2
0 quarters
|
|
336
Benitec Biopharma
BNTC
$344M
| $199K | ﹤0.01% |
14,874
-110,126
| -88% | -$1.31M |
2025 Q1
5 quarters
|
|
337
Perdoceo Education
PRDO
$1.7B
| $125K | ﹤0.01% |
+3,898
| New | +$134K |
2026 Q2
0 quarters
|
|
338
Janus Living Inc
JAN
$7.5B
| $81.7K | ﹤0.01% |
+2,844
| New | +$73.8K |
2026 Q2
0 quarters
|
|
|
PBLS
339
Parabilis Medicines Inc
PBLS
$3.75B
| $13.7K | ﹤0.01% |
+500
| New | +$13.8K |
2026 Q2
0 quarters
|
|
340
CALL
American Airlines Group
AAL
$9.38B
| – | – |
-1,550,000
| Closed | -$16.6M | – |
|
341
American Eagle Outfitters
AEO
$3.64B
| – | – |
-183,443
| Closed | -$3.06M | – |
|
342
Affirm
AFRM
$23.1B
| – | – |
-285,099
| Closed | -$13.1M | – |
|
343
CALL
Applied Materials
AMAT
$294B
| – | – |
-28,000
| Closed | -$9.6M | – |
|
|
344
Applied Materials
AMAT
$294B
| – | – |
-48,642
| Closed | -$16.6M | – |
|
345
Amgen
AMGN
$252B
| – | – |
-19,413
| Closed | -$6.83M | – |
|
346
Annexon
ANNX
$802M
| – | – |
-620,401
| Closed | -$3.44M | – |
|
347
Apollo Global Management
APO
$72.2B
| – | – |
-6,999
| Closed | -$780K | – |
|
348
Arrowhead Research
ARWR
$6.96B
| – | – |
-194,589
| Closed | -$12.2M | – |
|
349
Associated Banc-Corp
ASB
$5.74B
| – | – |
-405,311
| Closed | -$10.5M | – |
|
350
CALL
ASML
ASML
$583B
| – | – |
-5,000
| Closed | -$6.6M | – |
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.